Utilisation of extended release quetiapine (Seroquel XL™): Results from an observational cohort study in England.

@article{Osborne2016UtilisationOE,
  title={Utilisation of extended release quetiapine (Seroquel XL™): Results from an observational cohort study in England.},
  author={Vicki Osborne and Miranda Davies and Deborah Layton and Saad A. W. Shakir},
  journal={European psychiatry : the journal of the Association of European Psychiatrists},
  year={2016},
  volume={33},
  pages={61-67}
}
BACKGROUND A post-authorisation safety study was carried out as part of the EU Risk Management Plan to examine the long-term (up to 12 months) use of quetiapine XL as prescribed in general practice in England. AIM To present a description of the drug utilisation characteristics of quetiapine XL. METHODS An observational, population-based cohort design using the technique of Modified Prescription-Event Monitoring (M-PEM). Patients were identified from dispensed prescriptions issued by… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…